Food Supplements Based on Nettle and Peppermint to Control Signs and Symptoms Induced by Cancer Therapies

Inclusion Criteria: * Male or Female ≥ 18 years * Karnofsky Performance Scale (KPS) ≥ 90% * Breast or Gynecological cancer * Informed consent signed before every procedure study specific, on day 1 of therapy cycle * Inclusion Criteria Arm 1: presence of grade 1 anemia as per CTCAE 4.0 criteria; patients on treatment with anti-CDK 4/6 or PARP Inhibitors or in adjuvant therapy with hormone therapy * Inclusion Criteria Arm 2: presence of fatigue of any grade; patients on treatment with Epirubicin and Cyclophosphamide or Carboplatin and Taxane * Inclusion Criteria Arm 3: presence of nausea of any grade, without vomiting; patients on treatment with Epirubicin and Cyclophosphamide or Carboplatin and Taxane Exclusion Criteria: * Arm 1, 2 and 3: Previous intake of food supplements within 4 weeks from the enrollment * Arm 2: patients with evidence of anxiety or anxious-depressive syndrome; Clinical hypothyroidism not compensated by replacement therapy; Persistent insomnia * Arm 3: patients with evidence of anxiety or anxious-depressive syndrome